Dimitri A. Christakis, MD, MPH, discusses the clinical implications of a recent study showing that adults with intellectual and developmental disabilities have higher rates of anxiety and depression, pharmacologic utilization, and cost barriers compared to the general population.

ContributorDimitri A. Christakis, MD, MPH

Professor of Pediatrics
Director, Child Health Institute
University of Washington

Pediatrician
Seattle Children’s Hospital

Chief Health Officer
Special Olympics

---

Let us know what you thought of this week’s episode on X: @physicianswkly

Want to share your medical expertise, research, or unique experience in medicine on the podcast? Email us at editorial@physweekly.com.

Thanks for listening.

---

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Physician’s Weekly, their employees, and affiliates.